SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-585837
Filing Date
2016-05-10
Accepted
2016-05-10 17:25:31
Documents
34
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d145017d10q.htm 10-Q 202387
2 EX-31.1 d145017dex311.htm EX-31.1 8848
3 EX-31.2 d145017dex312.htm EX-31.2 8563
4 EX-32 d145017dex32.htm EX-32 4469
  Complete submission text file 0001193125-16-585837.txt   1362104

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pvct-20160331.xml EX-101.INS 133121
6 XBRL TAXONOMY EXTENSION SCHEMA pvct-20160331.xsd EX-101.SCH 25978
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pvct-20160331_cal.xml EX-101.CAL 27394
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pvct-20160331_def.xml EX-101.DEF 58490
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pvct-20160331_lab.xml EX-101.LAB 184439
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pvct-20160331_pre.xml EX-101.PRE 113588
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36457 | Film No.: 161637022
SIC: 2834 Pharmaceutical Preparations